Alteration in TSH levels during Ramadan in non fasting levothyroxine treated patients living with fasting family members
Methods: This observational before-and-after study, conducted between January 2023 and January 2024, included 116 hypothyroid patients on stable levothyroxine (LT4) therapy. Serum TSH, free thyroxine (fT4), and free triiodothyronine (fT3) levels were measured one month before and within one week after Ramadan. Patients were categorized as fasting or non-fasting, and completed a structured questionnaire regarding medication timing, fasting behavior, and lifestyle changes. Linear regression analysis was used to identify predictors of post-Ramadan TSH changes.
Results: TSH levels significantly increased after Ramadan in the overall cohort (mean±SD: 3.03±3.24 vs. 4.77±7.83 mU/L; P=0.028), while fT3 and fT4 levels remained unchanged (P=0.14 and P=0.72, respectively). Among fasting patients (n=72), TSH rose from 3.26±3.26 to 4.80±8.58 mU/L (P=0.47), whereas non-fasting patients (n=44) showed a significant increase from 2.65±3.21 to 4.73±6.51 mU/L (P=0.006). Polypharmacy was associated with increased odds of post-Ramadan TSH elevation (OR=2.67, 95% CI: 1.25–5.73, P=0.01). Among non-fasting patients, those who reported changes in sleep or meal patterns during Ramadan (n=28) experienced a significantly higher increase in TSH compared to those without such changes (ΔTSH: 2.47±3.88 vs. 0.81±2.12 mU/L, P=0.02).
Conclusions: Patients receiving LT4 therapy who do not fast during Ramadan may still exhibit significant TSH variability, likely due to behavioral and circadian disruptions. These findings emphasize the importance of proactive monitoring and targeted education for all hypothyroid patients during Ramadan, irrespective of fasting status.
1. Jonklaas J, Bianco AC, Bauer AJ, et al; American Thyroid Association Task Force on Thyroid Hormone Replacement. Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement. Thyroid. 2014;24(12):1670-1751. doi: 10.1089/thy.2014.0028.
2. Sheikh A, Mawani M, Mahar SA. Impact of Ramadan fasting on thyroid status and quality of life in patients with primary hypothyroidism: a prospective cohort study from Karachi, Pakistan. Endocr Pract. 2018;24(10):882-888. doi: 10.4158/EP-2018-0038.
3. El-Kaissi S, Dajani R, Lee-St John TJ, et al. Impact of Lifestyle Changes During Ramadan on Thyroid Function Tests in Hypothyroid Patients Taking Levothyroxine. Endocr Pract. 2020;26(7):748-753. doi: 10.4158/EP-2019-0505.
4. Caron P, Grunenwald S, Persani L, Borson-Chazot F, Leroy R, Duntas L. Factors influencing the levothyroxine dose in the hormone replacement therapy of primary hypothyroidism in adults. Rev Endocr Metab Disord. 2022;23(3):463-483. doi: 10.1007/s11154-021-09691-9.
5. Ikegami K, Refetoff S, Van Cauter E, Yoshimura T. Interconnection between circadian clocks and thyroid function. Nat Rev Endocrinol. 2019;15(10):590-600. doi: 10.1038/s41574-019-0237-z.
6. Nazem MR, Bastanhagh E, Emami A, Hedayati M, Samimi S, Karami M. The relationship between thyroid function tests and sleep quality: cross-sectional study. Sleep Sci. 2021;14(3):196-200. doi: 10.5935/1984-0063.20200050.
7. Belal MM, Youssef AR, Baker H, et al. Effect of Ramadan fasting on thyroid functions in hypothyroid patients taking levothyroxine: a systematic review and meta-analysis. Ir J Med Sci. 2024;193(2):741-753. doi: 10.1007/s11845-023-03526-z.
8. Alkaf B, Siddiqui M, Ali T, et al. Ramadan fasting and changes in thyroid function in hypothyroidism: identifying patients at risk. Thyroid. 2022;32(4):368-375. doi: 10.1089/thy.2021.0512.
9. Elsherbiny TM. Impact of fasting on thyrotropin and thyroid status during Ramadan in 292 previously well-controlled hypothyroid patients. IFTAR study. Endocrine. 2023;79(3):484-490. doi: 10.1007/s12020-022-03242-1.
10. Dellal FD, Ogmen B, Ozdemir D, et al. Effect of Ramadan fasting on thyroid hormone levels in patients on levothyroxine treatment. J Coll Physicians Surg Pak. 2020;30(10):1009-1014. doi: 10.29271/jcpsp.2020.10.1009.
11. Grindrod K, Alsabbagh W. Managing medications during Ramadan fasting. Can Pharm J (Ott). 2017;150(3):146-149. doi: 10.1177/1715163517700840.
12. Mahzari M, Al Remthi F, Ajwah I, et al. Levothyroxine timing during Ramadan: a randomized clinical trial. Int J Endocrinol. 2023;2023:2565031. doi: 10.1155/2023/2565031.
13. Al-Qahtani KM, Aldeeri IA, Alshaibi AM, et al. Optimal timing of thyroid hormone replacement during Ramadan fasting: a randomized controlled trial in patients with prior total thyroidectomy. Thyroid. 2022;32(9):1029-1036. doi: 10.1089/thy.2022.0110.
Copyright (c) 2025 The European Research Journal
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Downloads
Article Information
- Article Type Research Article
- Submitted February 21, 2026
- Published November 3, 2025
- Issue Vol. 11 No. 6 (2025)
- Section Research Article
